TKNONasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31

Alpha Teknova, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026

$6.80−0.28 (-3.95%)

Close on Oct 19, 2026

Market cap: $364.72M
P/E (TTM): –
Dividend yield: –

Alpha Teknova, Inc. cash flow statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31
Depreciation & Amortization	6.34	6.58	5.66	3.17	2.88	2.04
Stock-Based Compensation	3.43	3.67	4.14	3.71	1.55	0.30
Deferred Income Taxes	0.05	-0.09	-0.30	-1.93	-2.84	2.09
Other Non-Cash Items	–	–	–	–	0.01	-0.04
Change in Accounts Receivable	-0.37	-0.49	0.29	0.38	-0.28	-2.35
Change in Inventory	-2.37	0.24	0.33	-7.55	-2.25	-0.99
Change in Accounts Payable	0.47	-0.59	-0.77	0.57	0.27	0.87
Operating Cash Flow	-8.65	-12	-19	-27	-9.07	2.51
Capital Expenditures	-1.15	-1.13	-7.93	-28	-20	-5.47
Sale of Property, Plant & Equipment	0	0.13	0.20	0	–	–
Purchase of Investments	-17	-30	0	–	0	-1.76
Sale & Maturity of Investments	–	–	–	0	1.83	5.47
Investing Cash Flow	11	-27	-7.74	-28	-18	-1.74
Stock Issued	0	15	23	0	–	–
Debt Issued	–	–	0	10	12	–
Debt Repaid	–	0	-10	0	0	-0.05
Financing Cash Flow	0.15	15	13	10	111	-1.60
Net Change in Cash	2.20	-25	-14	-45	84	-0.83
Free Cash Flow	-9.79	-14	-27	-56	-29	-2.96
Income Taxes Paid	0.00	0.04	0	0	0.01	0.32
Interest Paid	1.46	1.55	1.75	0.10	0.41	0.04

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 34.6%
Operating margin: -36.2%
Net margin: -38.4%
Return on equity, FY2025: -22.8%

Financial strength

Current ratio: 4.49
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 87.4%

Valuation

P/E ratio: –
Price to sales: 8.35
Price to book: 5.83
Dividend yield: –